MedAvail to report Q2 2022 financial results on August 11, 2022

MISSISSAUGA, Ontario and PHOENIX–(BUSINESS THREAD)–MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), a pharmaceutical technology company, today announced that it will report financial results for the second quarter of 2022 on Thursday, August 11, 2022, after the market closes. MedAvail management will webcast a corresponding conference call beginning at 1:30 PM Pacific Time / 4:30 PM Eastern Time.

Live audio of the webcast will be available on the “Investor Relations” section of MedAvail’s website at: https://investors.medavail.com. The webcast will be archived and replayable after the event.

About MedAvail

MedAvail Holdings, Inc. (NASDAQ: MDVL) is a technology-enabled pharmaceutical organization that provides turnkey clinical pharmacy services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations to Medicare clinics. MedAvail helps patients optimize medication adherence, leading to better health outcomes. More information at www.medavail.com.

About SpotRx

SpotRx puts control of the pharmacy experience back in the hands of consumers. SpotRx is a telehealth platform that offers remote pharmacist consultations through an on-site dispensing kiosk, complemented by home delivery capability.

SOURCE MedAvail Holdings, Inc.



Source link

You May Also Like

About the Author: Chaz Cutler

My name is Chasity. I love to follow the stock market and financial news!